Post-infection gut dysbiosis drives systemic inflammation, leaky gut, and immune dysregulation all of which amplify fatigue, cognitive impairment, and mood instability.3 BPC-157 has been shown in multiple animal studies to: Accelerate healing of the intestinal epithelium4 Reduce gut inflammation and restore tight junction integrity5 Modulate the vagus nerve, which connects gut function to brain and immune signaling6 For long COVID patients dealing with GI symptoms, food intolerances, or fatigue that tracks with gut dysfunction, this mechanism is directly relevant
Within oligodendrocytes the OAA and acetyl-CoA serve to supply intermediates to the TCA cycle thereby, supporting energy production from the reduced electron carriers (NAHD and FADH 2 ) generated by the TCA cycle
While anecdotal reports often describe BPC-157 as well tolerated, these accounts are not a substitute for controlled clinical research
In the original mouse work it was described as well-tolerated, but that is the limit of the in-vivo safety evidence, and it is mouse-only
Patients benefit from free home delivery of their medication and unlimited access to medical professionals for check-ins
Transcriptional control of energy homeostasis in preclinical research models
